AKT1 and lung cancer: It was observed that betulinaldehyde suppresses the activation of Akt, MAPK, and STAT3 signaling pathways in A549 cells in a time-dependent manner and modulates intracellular autophagy levels, significantly inhibiting tumor activity in A549 cells, suggesting its potential as an effective adjuvant therapy for lung cancer (24).